1. "Population Sciences Research Program"
Formats
  1. Journal Article (7144)
  2. Meeting Abstract (3307)
  3. Book Section (330)
  4. Review (289)
  5. Editorial (253)
  6. Research Letter (116)
  7. Correspondence (111)
  8. Conference Paper (67)
  9. Guidelines (59)
  10. Miscellaneous (41)
  11. Book Whole (24)
Groups
  1. Population Sciences Research Program (11741)
  2. Survivorship Research (5670)
  3. Department of Medicine (5135)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3334)
  6. Surgery (2966)

More Groups

People
  1. Andrew Vickers (880)
  2. Kenneth Offit (788)
  3. Mark Robson (676)
  4. Steven Horwitz (645)
  5. T Peter Kingham (609)
  6. Katherine Panageas (512)

More People

Years
  1. 2025 (236)
  2. 2024 (722)
  3. 2023 (821)
  4. 2022 (828)
  5. 2021 (786)
  6. 2020 (738)

More Years

Publications
  1. Journal of Clinical Oncology (1246)
  2. Blood (374)
  3. Psycho-Oncology (347)
  4. Cancer (240)
  5. Cancer Research (234)
  6. Annals of Surgical Oncology (233)

More Publications

Publishers
  1. American Society of Clinical Oncology (1412)
  2. Elsevier Inc. (1128)
  3. Springer (1112)
  4. Elsevier Science, Inc. (816)
  5. Oxford University Press (753)
  6. Wiley Blackwell (614)

More Publishers

Results (11741)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Meaning-centered pain coping skills training: A pilot trial of a psychosocial intervention for patients with advanced cancer
    Meeting Abstract

    Winger, J. G.; Somers, T. J.; Steinhauser, K. E.; Porter, L. S.; Ramos, K.; Kamal, A. H.; Breitbart, W. S.; Keefe, F. J.
    Annals of Behavioral Medicine (2021)

    Fulltext@MSK | Save
  • Development of a communication training to promote advanced care planning for caregivers
    Meeting Abstract

    Gebert, R.; Haque, N. M.; Parker, P. A.; Diamond, E.; Applebaum, A. J.
    Annals of Behavioral Medicine (2021)

    Fulltext@MSK | Save
  • COVID-19 pandemic related concerns of Latino cancer patients: Perspectives of mental health providers from US and Latin America
    Meeting Abstract

    Costas-Muniz, R.; Montana, F.; Ruda-Santolaria, L.; Sanchez-Ramirez, J. C.; Torres-Blasco, N.; Castro, E. M.; Esenarro, L.; Galindo-Vazquez, O.; Breitbart, W. S.; Claros, M.; more...
    Annals of Behavioral Medicine (2021)

    Fulltext@MSK | Save
  • Delivery of mental health services to Latino cancer patients during the COVID-19 pandemic in Latin America and United States
    Meeting Abstract

    Costas-Muniz, R.; Galindo-Vazquez, O.; Montana, F.; Ruda-Santolaria, L.; Sanchez-Ramirez, J. C.; Torres-Blasco, N.; Castro, E. M.; Esenarro, L.; Claros, M.; Narang, B.; more...
    Annals of Behavioral Medicine (2021)

    Fulltext@MSK | Save
  • Addressing financial toxicity in young adult cancer: Exploring the impact of one-time financial grants
    Meeting Abstract

    Thom, B.; Benedict, C.; Landwehr, M.; Watson, S.
    Annals of Behavioral Medicine (2021)

    Fulltext@MSK | Save
  • Coping with cancer-related financial distress
    Meeting Abstract

    Thom, B.; Doherty, M. J.
    Annals of Behavioral Medicine (2021)

    Fulltext@MSK | Save
  • A qualitative study of unintentional tanning among college students
    Meeting Abstract

    Bowers, J. M.; DiFonzo, J. T.; Hay, J. L.
    Annals of Behavioral Medicine (2021)

    Fulltext@MSK | Save
  • First‐in‐human study of the EZH1 and EZH2 dual inhibitor valemetostat tosylate (DS‐3201b) in patients with relapsed or refractory non‐Hodgkin lymphomas
    Meeting Abstract

    Ishitsuka, K.; Izutsu, K.; Maruyama, D.; Makita, S.; Jacobsen, E. D.; Horwitz, S.; Kusumoto, S.; Allen, P.; Porcu, P.; Imaizumi, Y.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Cardiotoxicity risk in patients with non‐Hodgkin lymphoma receiving epoch after prior anthracycline exposure
    Meeting Abstract

    Buege, M. J.; Dao, P. H.; Drill, E.; Horwitz, S. M.; LeVoir, A.; Pak, T.; Peterson, T. J.; Matasar, M. J.
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • A phase II trial of reduced dose brentuximab vedotin for cutaneous T‐cell lymphomas
    Meeting Abstract

    Khan, N.; Noor, S.; Geller, S.; Khodadoust, M. S.; Kheterpal, M.; Hancock, H.; Davey, T.; Ryu, S.; Perez, L.; Lares, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save